Abstracts

SAME-DAY ART IN THAILAND: THE IMPACT OF ART INITIATION PERIODS ON TREATMENT OUTCOMES

Despite the World Health Organization’s recommendation on same-day antiretroviral therapy (ART) for clients who are ready, there are still concerns around the effect of immediate ART on care outcomes. This study evaluates the influence of different ART initiation durations on retention, viral load suppression, and adverse events on clinically-eligible clients in same-day ART cohort in…

SEXUAL VIOLENCE EXPOSURE DYSREGULATES HIV-ASSOCIATED IMMUNE BIOMARKERS IN WOMEN

HIV/AIDS and sexual violence act synergistically to adversely and disproportionately impact women’s health. Yet immuno-biological mechanisms linking sexual violence and increased HIV susceptibility are incompletely understood. We aimed to determine systemic and mucosal immune dysregulation in women who had experienced recent sexual violence. We conducted a cross-sectional study of premenopausal, HIV-negative women from the Washington…

ELEVATED GENITAL CYTOKINES IN HIV-INFECTED WOMEN USING COPPER AND LEVONORGESTREL IUDs

Intrauterine contraceptive devices (IUCD) may increase genital inflammatory cytokine concentrations in HIV+ women despite antiretroviral therapy (ART). We compared the effect of copper (cIUCD) versus levonorgestrel intrauterine system (LNG-IUS) on genital cytokines in both ART using (ART+) and non-ART using (ART-) women. In a secondary analysis of an RCT, menstrual cup cervicovaginal secretions (CVS) were…

COPPER IUD AND LEVONORGESTREL IMPLANT INCREASE GENITAL INFLAMMATION IN THE ECHO TRIAL

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial found no substantial difference in HIV acquisition risk between women randomised to injectable depot medroxyprogesterone acetate (DMPA-IM), copper intrauterine device (IUD) or the levonorgestrel (LNG) implant. However, ECHO did not address whether these contraceptives increase HIV risk relative to other contraceptive methods or to no…

INCREASED GENITAL INFLAMMATION IN WOMEN RANDOMIZED TO COPPER IUD IN THE ECHO TRIAL

The inflammatory milieu of the lower female genital tract contributes substantially to HIV acquisition risk. In the randomized ECHO trial, we investigated whether the intramuscular injectable depo-medroxyprogesterone acetate (DMPA-IM) influenced genital inflammation, relative to the levonorgestrel implant (LNG-Implant) and non-hormonal copper intrauterine device (Copper-IUD). Cervicovaginal secretions (CVS) were collected via menstrual cups at three sites…